Abuse of FDA Citizen Petitions
Did you know that: A drug company petitioned the FDA to ban a B vitamin in order to protect its own drug product?
Did you know that: A drug company petitioned the FDA to ban a B vitamin in order to protect its own drug product?
The latest attack on bio-identical hormones comes from FDA staffers telling Congress that even though estriol is the weakest estrogen, it is being prescribed to women in “mega dosages.” They are saying that this makes it potentially harmful, which is why they are insisting on doctors having to file an IND (investigational new drug) application.
AAHF is pleased to announce that the Food and Drug Administration must now classify mercury fillings! We congratulate Consumers for Dental Choices, Moms Against Mercury, International Academy of Oral and Metal Toxicology, and all other groups and individuals who have dedicated years to the issue of the dangers of dental mercury.
If you haven’t taken action yet, please do so now! We have also heard that the Wyeth is already gearing up to fight this tooth and nail. We have also learned that Wyeth is coordinating women’s groups to write letters in opposition of the resolution. We need you to help spread the word and fight Big Pharma and their controlling ties to the FDA.
From our friends at Consumers for Dental Choice comes news that the Food & Drug Administration, Associate Commissioner Norris Alderson has declared that mercury amalgams are “…not for MY grandchildren.”
The Food and Drug Administration (FDA) recently released a Public Health Advisory on Edetate Disodium (EDTA). The advisory reflects FDA’s current analysis of data available concerning this drug. The advisory is meant to alert patients and healthcare professionals about EDTA.
Thousands of cases of breast and colon cancers might be averted each year if people in colder climates raised their vitamin D levels, researchers estimate in a new report. A number of studies have suggested that vitamin D may be important in cancer risk. Much of this research is based on cancer rates at different […]
U.S. District Court Judge Robert Junell ruled on August 30 that “it is in the best interest of public health” to uphold the legality of compounded drugs. In the past, FDA had proposed that, even though it is impossible to do so, compounded medicines must meet the same new drug requirements to which mass produced, […]